 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Trial of a Drug to Decrease the Risk for Heart Disease in Patients with Mild Kidney Failure
17 April 2001 | Volume 134 Issue 8 | Page S96
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial." It is in the 17 April 2001 issue of Annals of Internal Medicine (volume 134, pages 629-636). The authors are JFE Mann, HC Gerstein, J Pogue, J Bosch, and S Yusuf, for the HOPE Investigators.
What is the problem and what is known about it so far?
Severe kidney disease is known to increase the risk for heart (cardiac) disease, but it is not known whether mildly abnormal kidney function increases heart disease risk. The Heart Outcomes and Prevention Evaluation (HOPE) study evaluated people at high risk for heart disease from many causes and the effects of ramipril (a special class of drug that lowers blood pressure) on that risk. This study included many people with mild kidney disease.
Why did the researchers do this particular study?
The researchers reanalyzed the data from the HOPE study to find out whether mild kidney disease itself increased the risk for cardiac disease and whether ramipril could be protective in this particular group of patients.
Who was studied?
9297 patients in the HOPE study who were at high risk for cardiac disease for a variety of reasons.
How was the study done?
Tests of kidney function were performed at the beginning of the study. The participants were then randomly assigned to treatment with either ramipril or an inactive placebo pill and were followed for 3.5 to 5.5 years. Because high blood pressure and diabetes can cause heart disease by themselves, patients with those disorders were analyzed separately. The primary outcomes studied were cardiac death, heart attack, or stroke. Outcomes of secondary interest were the total number of deaths, hospitalizations for heart failure, and performance of surgical procedures to increase blood flow to the heart.
What did the researchers find?
980 participants fulfilled the criteria for mild kidney disease. These people were older; were more likely to be men; had higher blood pressure, more coronary artery disease, and lower levels of "good cholesterol" (high-density lipoprotein cholesterol); and used more medicines to prevent heart attacks and high blood pressure than those with normal kidney function. Even taking those factors into account, mildly abnormal kidney function itself was an important predictor of heart disease. The more abnormal the kidney function, the higher the risks for heart disease and death from any cause. Ramipril substantially reduced the risk for bad outcomes in the patients with reduced kidney function. Ramipril produced no more adverse side effects than did placebo.
What were the limitations of the study?
Reanalysis of data collected for another purpose is not the best way to answer a particular medical question. Also, the data may not apply to the general population since the people studied had preexisting blood vessel disease or had diabetes with at least one other risk factor for heart disease.
What are the implications of the study?
Mild kidney disease should be considered a risk factor for heart disease; drugs such as ramipril may help reduce this risk.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Fukuda, M. Mizuno, T. Yamanaka, M. Motokawa, Y. Shirasawa, T. Nishio, S. Miyagi, A. Yoshida, and G. Kimura Patients With Renal Dysfunction Require a Longer Duration Until Blood Pressure Dips During the Night Hypertension, December 1, 2008; 52(6): 1155 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Fang, D. G. Oreopoulos, and J. M. Bargman Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3704 - 3710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. K. M. Windt, R. H. Henning, A. C. A. Kluppel, Y. Xu, D. de Zeeuw, and R. P. E. van Dokkum Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3103 - 3110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chonchol, H. Gnahn, and D. Sander Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2593 - 2598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ovbiagele Impairment in Glomerular Filtration Rate or Glomerular Filtration Barrier and Occurrence of Stroke Arch Neurol, July 1, 2008; 65(7): 934 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Farbom, B. Wahlstrand, P. Almgren, S. Skrtic, J. Lanke, L. Weiss, S. Kjeldsen, T. Hedner, and O. Melander Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension: The Nordic Diltiazem Study Hypertension, July 1, 2008; 52(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dimopoulos, G.-P. Diller, E. Koltsida, A. Pijuan-Domenech, S. A. Papadopoulou, S. V. Babu-Narayan, T. V. Salukhe, M. F. Piepoli, P. A. Poole-Wilson, N. Best, et al. Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease Circulation, May 6, 2008; 117(18): 2320 - 2328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Jaar, R. Khatib, L. Plantinga, L. E. Boulware, and N. R. Powe Principles of Screening for Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 601 - 609. [Full Text] [PDF]
|
|
|
|
|
|
J. F. E. Mann, P. Sheridan, M. J. McQueen, C. Held, J. M. O. Arnold, G. Fodor, S. Yusuf, E. M. Lonn, and on behalf of the HOPE-2 investigators Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study Nephrol. Dial. Transplant., February 1, 2008; 23(2): 645 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Steigerwalt Management of Hypertension in Diabetic Patients With Chronic Kidney Disease Diabetes Spectr, January 1, 2008; 21(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. van Domburg, S. E. Hoeks, G. M.J.M. Welten, M. Chonchol, A. Elhendy, and D. Poldermans Renal Insufficiency and Mortality in Patients with Known or Suspected Coronary Artery Disease J. Am. Soc. Nephrol., January 1, 2008; 19(1): 158 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Brugts, E. Boersma, M. Chonchol, J. W. Deckers, M. Bertrand, W. J. Remme, R. Ferrari, K. Fox, M. L. Simoons, and on behalf of the EUROPA Investigators The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency: Insights From the EUROPA Trial J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2148 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bax, L. H. Young, R. L. Frye, R. O. Bonow, H. O. Steinberg, and E. J. Barrett Screening for Coronary Artery Disease in Patients With Diabetes Diabetes Care, October 1, 2007; 30(10): 2729 - 2736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Perkovic, T. Ninomiya, H. Arima, M. Gallagher, M. Jardine, A. Cass, B. Neal, S. MacMahon, and J. Chalmers Chronic Kidney Disease, Cardiovascular Events, and the Effects of Perindopril-Based Blood Pressure Lowering: Data from the PROGRESS Study J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2766 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Daly Is early chronic kidney disease an important risk factor for cardiovascular disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix19 - ix25. [Full Text] [PDF]
|
|
|
|
|
|
W. W. M. Saweirs and J. Goddard What are the best treatments for early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix31 - ix38. [Full Text] [PDF]
|
|
|
|
|
|
E. Suganuma, V. R. Babaev, M. Motojima, Y. Zuo, N. Ayabe, A. B. Fogo, I. Ichikawa, M. F. Linton, S. Fazio, and V. Kon Angiotensin Inhibition Decreases Progression of Advanced Atherosclerosis and Stabilizes Established Atherosclerotic Plaques J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2311 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Foster, S.-J. Hwang, M. G. Larson, N. I. Parikh, J. B. Meigs, R. S. Vasan, T. J. Wang, D. Levy, and C. S. Fox Cross-Classification of Microalbuminuria and Reduced Glomerular Filtration Rate: Associations Between Cardiovascular Disease Risk Factors and Clinical Outcomes Arch Intern Med, July 9, 2007; 167(13): 1386 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann Chronic Kidney Disease: Effects on the Cardiovascular System Circulation, July 3, 2007; 116(1): 85 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, and J. Stessman Glomerular filtration rate estimation and mortality in an elderly population QJM, July 1, 2007; 100(7): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough, C. T. Jurkovitz, P. E. Pergola, J. B. McGill, W. W. Brown, A. J. Collins, S.-C. Chen, S. Li, A. Singh, K. C. Norris, et al. Independent Components of Chronic Kidney Disease as a Cardiovascular Risk State: Results From the Kidney Early Evaluation Program (KEEP) Arch Intern Med, June 11, 2007; 167(11): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gianni, J. Bosch, J. Pogue, J. Probstfield, G. Dagenais, S. Yusuf, and E. Lonn Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients Eur. Heart J., June 1, 2007; 28(11): 1382 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bro, C. J. Binder, J. L. Witztum, K. Olgaard, and L. B. Nielsen Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1080 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kottgen, S. D. Russell, L. R. Loehr, C. M. Crainiceanu, W. D. Rosamond, P. P. Chang, L. E. Chambless, and J. Coresh Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1307 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Levey, S. P. Andreoli, T. DuBose, R. Provenzano, and A. J. Collins Chronic Kidney Disease: Common, Harmful, and Treatable--World Kidney Day 2007 Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 401 - 405. [Full Text] [PDF]
|
|
|
|
|
|
B. R. Hemmelgarn, B. J. Manns, J. Zhang, M. Tonelli, S. Klarenbach, M. Walsh, B. F. Culleton, and for the Alberta Kidney Disease Network Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., March 1, 2007; 18(3): 993 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.R. Hemmelgarn, B.F. Culleton, and W.A. Ghali Derivation and validation of a clinical index for prediction of rapid progression of kidney dysfunction QJM, February 1, 2007; 100(2): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Portoles, J. M. Lopez-Gomez, P. Aljama, and on behalf of the MAR Study Group A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study Nephrol. Dial. Transplant., February 1, 2007; 22(2): 500 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Levey, S. P. Andreoli, T. DuBose, R. Provenzano, and A. J. Collins Chronic Kidney Disease: Common, Harmful, and Treatable--World Kidney Day 2007 J. Am. Soc. Nephrol., February 1, 2007; 18(2): 374 - 378. [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, W.-Y. So, A. P.S. Kong, C.-S. Ho, C. W.K. Lam, R. J. Stevens, R. R. Lyu, D. D. Yin, C. S. Cockram, P. C.Y. Tong, et al. Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes: The Hong Kong Diabetes Registry Diabetes Care, January 1, 2007; 30(1): 65 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ruggenenti and G. Remuzzi Kidney Failure Stabilizes after a Two-Decade Increase: Impact on Global (Renal and Cardiovascular) Health Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 146 - 150. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers Eur. Heart J., December 2, 2006; 27(24): 2975 - 2981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gomez, L. M. Ruilope, V. Barrios, J. Navarro, M. A. Prieto, O. Gonzalez, L. Guerrero, M. A. S. Zamorano, C. Filozof, and on behalf of the FATH Study Group Prevalence of Renal Insufficiency in Individuals with Hypertension and Obesity/Overweight: The FATH Study J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S194 - S200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A.K.M. Windt, W. B.A. Eijkelkamp, R. H. Henning, A. C.A. Kluppel, P. A. de Graeff, H. L. Hillege, S. Schafer, D. de Zeeuw, and R. P.E. van Dokkum Renal Damage after Myocardial Infarction Is Prevented by Renin-Angiotensin-Aldosterone-System Intervention J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3059 - 3066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Norris, T. Greene, J. Kopple, J. Lea, J. Lewis, M. Lipkowitz, P. Miller, A. Richardson, S. Rostand, X. Wang, et al. Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2928 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wattanakit, J. Coresh, P. Muntner, J. Marsh, and A. R. Folsom Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF]
|
|
|
|
|
|
W. Y. So, A. P.S. Kong, R. C.W. Ma, R. Ozaki, C. C. Szeto, N. N. Chan, V. Ng, C. S. Ho, C. W.K. Lam, C. C. Chow, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care, September 1, 2006; 29(9): 2046 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Dworkin Controversial Treatment of Atherosclerotic Renal Vascular Disease: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions Trial Hypertension, September 1, 2006; 48(3): 350 - 356. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Strauss and A. S. Hall Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox Circulation, August 22, 2006; 114(8): 838 - 854. [Full Text] [PDF]
|
|
|
|
|
|
N. Volkova, W. McClellan, J. M. Soucie, and A. Schoolwerth Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2202 - 2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Koren-Morag, U. Goldbourt, and D. Tanne Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology, July 25, 2006; 67(2): 224 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg Chronic Kidney Disease and Mortality Risk: A Systematic Review J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sandhu, N. Wiebe, L. F. Fried, and M. Tonelli Statins for Improving Renal Outcomes: A Meta-Analysis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2006 - 2016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tonelli, P. Jose, G. Curhan, F. Sacks, E. Braunwald, M. Pfeffer, and Cholesterol and Recurrent Events (CARE) Trial Inve Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial BMJ, June 17, 2006; 332(7555): 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.S. MacGregor, D.E. Boag, and A. Innes Chronic kidney disease: evolving strategies for detection and management of impaired renal function QJM, June 1, 2006; 99(6): 365 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Nguyen and A. G. Stack Ethnic Disparities in Cardiovascular Risk Factors and Coronary Disease Prevalence among Individuals with Chronic Kidney Disease: Findings from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Hemmelgarn, D. A. Southern, K. H. Humphries, B. F. Culleton, M. L. Knudtson, W. A. Ghali, and for the Alberta Provincial Project for Outcomes As Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization Eur. Heart J., May 2, 2006; 27(10): 1191 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
Article
